CompletedNCT05415904
Hantavirus Nephropathy in North-Eastern France : Severity Risk Factors and Prognostic Tools
Studying Hantavirus pulmonary syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Central Hospital, Nancy, France
- Principal Investigator
- Alice CORBEL, M.D.Central Hospital, Nancy, France
- Intervention
- HANTA-NE(other)
- Enrollment
- 101 enrolled
- Eligibility
- 18-125 years · All sexes
- Timeline
- 2022 – 2024
Study locations (1)
- Central Hospital, Nancy, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05415904 on ClinicalTrials.govOther trials for Hantavirus pulmonary syndrome
Additional recruiting or active studies for the same condition.